Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
TheraVida began a double-blind, placebo-controlled, crossover, international Phase II trial in 120 female patients to compare 2 mg THVD-201 vs. 2 mg Detrol LA tolterodine tartrate for 16 weeks. Patie...